{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:19:58Z","timestamp":1794863998265,"version":"4.9.1"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although mortality from acute myocardial infarction (AMI) has declined historically, the burden remains substantial. This study evaluated long-term temporal trends and population-level disparities in AMI-related mortality among US adults aged \u2265 45 years from 1999 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Mortality data were retrieved from the CDC WONDER underlying cause of death (UCD) and Multiple Cause of Death (MCD) datasets. We identified death records listing AMI (ICD-10: I21\u2013I22) as the cause of death. Crude mortality rates and age-adjusted mortality rates (AAMRs) per 100,000 population were calculated, with standardization to the 2000 US population. Joinpoint regression models were employed to estimate the annual percent change (APC) and average annual percent change (AAPC). To ensure robustness, a sensitivity analysis was conducted using the MCD dataset, defining AMI as a contributing cause of death with cardiovascular disease (ICD-10: I00\u2013I99) as an underlying cause of death.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 3,255,707 AMI-related deaths were analyzed. The overall AAMR decreased from 206.12 (95% CI: 205.21\u2013207.03) in 1999 to 60.71 (95% CI: 60.31\u201361.11) in 2023, with an overall AAPC of \u22124.94%. Joinpoint analysis identified decline during 1999\u20132018, followed by a plateau during 2018\u20132021 (APC: \u22120.02%) and a subsequent accelerated decline during 2021\u20132023 (APC: \u22128.74%). While male AAMRs remained consistently higher than female AAMRs (81.86 vs. 43.12 in 2023), females exhibited a faster rate of decline (AAPC: \u22125.30% vs. \u22124.87%). Racial disparities persisted, with non-Hispanic Black individuals showing higher mortality than non-Hispanic White individuals. Urban-rural analysis (1999\u20132020) revealed that rural areas faced the highest mortality burden and the slowest decline (AAPC: \u22123.92%) compared to large metropolitan areas (AAPC: \u22125.58%). Sensitivity analyses yielded results consistent with the primary findings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite a significant long-term reduction in AMI-related mortality in the United States, progress has been uneven, characterized by a phase-specific plateau and persistent geographic and racial disparities. Targeted public health strategies and resource allocation are essential to address the high burden in rural areas and among vulnerable populations to further reduce health inequities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1817513","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:40:26Z","timestamp":1779169226000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Trends in acute myocardial infarction mortality in the United States, 1999\u20132023"],"prefix":"10.3389","volume":"13","author":[{"given":"Jiayin","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, North China University of Science and Technology","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhui","family":"Pei","sequence":"additional","affiliation":[{"name":"Department of Immunology, School of Elementary Medicine, North China University of Science and Technology","place":["Tangshan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e618","DOI":"10.1161\/CIR.0000000000000617","article-title":"Fourth universal definition of myocardial infarction (2018).","volume":"138","author":"Thygesen","year":"2018","journal-title":"Circulation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980-2000.","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1001\/jama.2019.9161","article-title":"Trends in cardiometabolic mortality in the United States, 1999-2017.","volume":"322","author":"Shah","year":"2019","journal-title":"JAMA."},{"key":"B4","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.115.015293","article-title":"Coronary Heart disease mortality declines in the United States from 1979 through 2011: evidence for stagnation in young adults, especially women.","volume":"132","author":"Wilmot","year":"2015","journal-title":"Circulation."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1001\/jama.2020.2047","article-title":"Rural-Urban differences in cardiovascular mortality in the US, 1999-2017.","volume":"323","author":"Cross","year":"2020","journal-title":"JAMA."},{"key":"B6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jacc.2020.10.055","article-title":"Cardiovascular deaths during the COVID-19 pandemic in the United States.","volume":"77","author":"Wadhera","year":"2021","journal-title":"J Am Coll Cardiol."},{"key":"B7","first-page":"408","article-title":"CDC WONDER on the Web.","author":"Friede","year":"1996","journal-title":"Proc AMIA Annu Fall Symp."},{"key":"B8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:33.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"102010","DOI":"10.1016\/j.jacadv.2025.102010","article-title":"CDC WONDER: Trends in acute myocardial infarction mortality in the United States From 1968 to 2021","volume":"4","author":"Waqas","year":"2025","journal-title":"JACC Adv."},{"key":"B10","doi-asserted-by":"publisher","first-page":"100499","DOI":"10.1016\/j.ahjo.2025.100499","article-title":"Underlying and contributing causes of mortality from CDC WONDER\u2014Insights for researchers.","volume":"50","author":"Sperling","year":"2025","journal-title":"Am Heart J Plus."},{"key":"B11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5114\/amsad\/199656","article-title":"Trends of acute myocardial infarction-related deaths in US patients from 1999 to 2020.","volume":"9","author":"Ullah","year":"2024","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"B12","first-page":"1","article-title":"2013 NCHS urban-rural classification scheme for counties","volume":"166","author":"Ingram","year":"2014","journal-title":"Vital Health Stat 2."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa0908610","article-title":"Population trends in the incidence and outcomes of acute myocardial infarction.","volume":"362","author":"Yeh","year":"2010","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e191938","DOI":"10.1001\/jamanetworkopen.2019.1938","article-title":"Twenty-Year trends in outcomes for older adults with acute myocardial infarction in the United States.","volume":"2","author":"Krumholz","year":"2019","journal-title":"JAMA Netw Open."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1161\/CIR.0b013e3182742cf6","article-title":"2013 ACCF\/AHA guideline for the management of st-elevation myocardial infarction.","volume":"127","author":"O\u2019Gara","year":"2013","journal-title":"Circulation."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/CIR.0000000000000134","article-title":"2014 AHA\/ACC guideline for the management of patients with Non\u2013ST-Elevation acute coronary syndromes.","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e368","DOI":"10.1161\/CIR.0000000000001030","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: executive summary.","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation."},{"key":"B18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1056\/NEJMsa063117","article-title":"Strategies for reducing the Door-to-Balloon time in acute myocardial infarction.","volume":"355","author":"Bradley","year":"2006","journal-title":"N Engl J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2020.04.011","article-title":"Reduction in ST-Segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic.","volume":"75","author":"Garcia","year":"2020","journal-title":"J Am Coll Cardiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1056\/NEJMc2015630","article-title":"The Covid-19 pandemic and the incidence of acute myocardial infarction.","volume":"383","author":"Solomon","year":"2020","journal-title":"N Engl J Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/S0140-6736(20)31356-8","article-title":"COVID-19 pandemic and admission rates for and management of acute coronary syndromes in england.","volume":"396","author":"Mafham","year":"2020","journal-title":"Lancet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/jama.2018.3060","article-title":"Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016.","volume":"319","author":"Hales","year":"2018","journal-title":"JAMA."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988-2012.","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999-2000 to 2017-2018.","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA."},{"key":"B27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1161\/CIR.0000000000000228","article-title":"Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American Heart Association.","volume":"132","author":"Havranek","year":"2015","journal-title":"Circulation."},{"key":"B28","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIR.0000000000000351","article-title":"Acute myocardial infarction in women: a scientific statement from the American Heart Association.","volume":"133","author":"Mehta","year":"2016","journal-title":"Circulation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1001\/jama.2012.199","article-title":"Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality.","volume":"307","author":"Canto","year":"2012","journal-title":"JAMA."},{"key":"B30","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0140-6736(88)92833-4","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.","volume":"2","year":"1988","journal-title":"Lancet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial.","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes.","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes.","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes.","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes.","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease.","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome.","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control.","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"CD001800","DOI":"10.1002\/14651858.CD001800.pub3","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease.","volume":"1","author":"Anderson","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"B41","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1001\/jama.290.1.86","article-title":"Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review.","volume":"290","author":"Critchley","year":"2003","journal-title":"JAMA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction.","volume":"372","author":"Bonaca","year":"2015","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1817513\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:40:29Z","timestamp":1779169229000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1817513\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":42,"alternative-id":["10.3389\/fmed.2026.1817513"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1817513","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fmed.2026.1817513.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fmed.2026.1817513.s002","asserted-by":"subject"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"article-number":"1817513"}}